What is a TAVR heart procedure?

TAVR (Transcatheter Aortic Valve Replacement) Procedure: An Innovative Approach to Heart Valve Treatment


Heart valve disease is a serious condition that affects millions of people worldwide. In the past, surgical intervention was the primary treatment option for patients with severe valve disease. However, advancements in medical technology have led to the development of minimally invasive procedures such as Transcatheter Aortic Valve Replacement (TAVR). This innovative technique allows for the replacement of damaged heart valves without the need for open-heart surgery. In this article, we will explore the TAVR procedure in detail, including its benefits, indications, the procedural steps involved, and potential risks and complications.

Understanding Heart Valve Disease:

To comprehend the significance of the TAVR procedure, it is essential to have a basic understanding of heart valve disease. The heart has four valves, namely the aortic valve, mitral valve, tricuspid valve, and pulmonary valve. These valves ensure the unidirectional flow of blood through the heart, allowing it to pump efficiently.

Heart valve disease occurs when one or more of these valves become damaged or dysfunctional. The most common types of valve disease include aortic stenosis (narrowing of the aortic valve), mitral regurgitation (leaking of the mitral valve), and tricuspid regurgitation (leaking of the tricuspid valve). Valve disease can lead to symptoms such as shortness of breath, chest pain, fatigue, and fluid retention, severely impacting a patient’s quality of life.

Traditional Valve Replacement vs. Transcatheter Valve Replacement:

Traditionally, valve replacement surgery involved a sternotomy (a large incision in the chest) and the use of a heart-lung bypass machine. While effective, this method has certain drawbacks, including increased risk, prolonged recovery time, and a higher incidence of complications, particularly in elderly or high-risk patients.

Transcatheter Valve Replacement, also known as Transcatheter Aortic Valve Replacement (TAVR), revolutionized the field of heart valve treatment. Initially, TAVR was developed specifically for patients with severe aortic stenosis, but its applications have expanded to include other valves as well. The TAVR procedure involves the percutaneous (through the skin) insertion of a new valve within the diseased valve, using a catheter-based delivery system.

Indications for TAVR:

The TAVR procedure is typically recommended for patients with severe heart valve disease who are considered high risk or inoperable candidates for traditional surgery. It is crucial to evaluate each patient individually to determine their eligibility for TAVR. Some common indications for TAVR include:

1. Severe aortic stenosis with symptoms: Aortic stenosis occurs when the aortic valve becomes narrowed, restricting blood flow from the heart. If a patient experiences symptoms such as chest pain, shortness of breath, or fatigue, TAVR may be a suitable treatment option.

2. Failed bioprosthetic valve: In cases where a previously implanted artificial valve fails or deteriorates, TAVR can be used to replace it, avoiding the need for repeat open-heart surgery.

3. High-risk surgical patients: Patients with multiple comorbidities, advanced age, or compromised lung or kidney function may be deemed too high-risk for traditional surgery. TAVR offers a minimally invasive alternative with reduced risks and faster recovery.

Procedure Steps:

The TAVR procedure is typically performed in a specialized cardiac catheterization laboratory or hybrid operating room. The following steps outline the general process involved in TAVR:

1. Patient Preparation: The patient undergoes a thorough pre-procedural evaluation, including medical history, physical examination, imaging studies (echocardiography, CT scan), and blood tests. An anesthesiologist evaluates the patient for the

 appropriate level of anesthesia.

2. Access Site Selection: The physician determines the best access site for the catheter insertion. The most common access points include the femoral artery (groin), subclavian artery (under the collarbone), or direct aortic access (small incision in the chest).

3. Catheter Insertion: A small incision is made at the chosen access site, and a sheath is inserted into the artery or vein. Through this sheath, a flexible catheter is advanced towards the heart, guided by imaging techniques such as fluoroscopy or transesophageal echocardiography.

4. Valve Deployment: Once the catheter reaches the diseased valve, the new valve, mounted on a balloon-expandable or self-expanding stent, is positioned within the existing valve. The balloon is inflated to deploy the new valve, which pushes aside the old valve leaflets and becomes the new functional valve.

5. Valve Assessment: After deployment, the physician assesses the new valve’s position and function using imaging modalities, ensuring proper alignment and absence of significant leakage.

6. Catheter Removal and Closure: Once the new valve is securely in place, the catheter is removed, and the access site is closed using closure devices, sutures, or manual compression. This step may vary depending on the access site and the physician’s preference.

Post-Procedure and Recovery:

Following the TAVR procedure, patients are closely monitored in a cardiac care unit or an intensive care unit for a day or two. Vital signs, heart rhythm, and valve function are continuously assessed. Most patients experience a significant improvement in symptoms soon after the procedure, such as reduced shortness of breath and improved exercise tolerance.

The recovery time after TAVR is considerably shorter compared to traditional surgery. Patients are usually able to get out of bed within a day and are discharged from the hospital within a few days, depending on their overall condition and recovery progress. Cardiac rehabilitation and follow-up visits are essential components of the recovery process, enabling patients to regain their strength and monitor the long-term function of the new valve.

Risks and Complications:

While TAVR offers several advantages, it is important to acknowledge potential risks and complications associated with the procedure. These can include:

1. Vascular complications: Bleeding, hematoma, or damage to the blood vessels at the access site.

2. Stroke: There is a small risk of stroke during the procedure due to dislodgment of debris or formation of blood clots.

3. Valve malposition or embolization: Improper positioning or displacement of the new valve, which may require additional intervention.

4. Arrhythmias: Irregular heart rhythms, such as atrial fibrillation, may occur during or after the procedure.

5. Infection: Although rare, infections can develop at the access site or involve the heart valve itself.


Transcatheter Aortic Valve Replacement (TAVR) has revolutionized the field of heart valve treatment, providing a less invasive alternative to traditional open-heart surgery. The procedure offers numerous benefits, including reduced risk, faster recovery, and improved quality of life for patients with severe valve disease. While TAVR is primarily used for aortic valve replacement, it has expanded to include other valves as well. Proper patient selection, meticulous procedural techniques, and careful post-procedural management are crucial for optimal outcomes. As medical technology continues to advance, TAVR holds the promise of further improving patient care and outcomes in the field of heart valve disease treatment.If you do not see answers to your questions here, please contact us.